134 related articles for article (PubMed ID: 35537594)
1. Globally Vibrio cholera antibiotics resistance to RNA and DNA effective antibiotics: A systematic review and meta-analysis.
Rostami A; Zadeh FA; Ebrahimzadeh F; Jafari-Sales A; Gholami S
Microb Pathog; 2022 Nov; 172():105514. PubMed ID: 35537594
[TBL] [Abstract][Full Text] [Related]
2. Global status of antimicrobial resistance among environmental isolates of Vibrio cholerae O1/O139: a systematic review and meta-analysis.
Yuan XH; Li YM; Vaziri AZ; Kaviar VH; Jin Y; Jin Y; Maleki A; Omidi N; Kouhsari E
Antimicrob Resist Infect Control; 2022 Apr; 11(1):62. PubMed ID: 35468830
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial resistance in
Liu C; Wang Y; Azizian K; Omidi N; Hassan Kaviar V; Kouhsari E; Maleki A
Expert Rev Anti Infect Ther; 2022 Sep; 20(9):1217-1231. PubMed ID: 35790112
[TBL] [Abstract][Full Text] [Related]
4. Minimum inhibitory concentration (MIC) of some antibiotics against Vibrio cholerae O139 isolates from Pondicherry.
Vijayalakshmi N; Rao RS; Badrinath S
Epidemiol Infect; 1997 Aug; 119(1):25-8. PubMed ID: 9287939
[TBL] [Abstract][Full Text] [Related]
5. [Experimental resistance of Vibrio cholerae el tor to nalidixic acid and fluoroquinolones].
Ryzhko IV; Tsuraeva RI; Lomov IuM; Shut'ko AG; Mishan'kin BN; Koroleva NS; Samokhodkina ED; Shcherbaniuk AI
Antibiot Khimioter; 2000; 45(9):7-12. PubMed ID: 11057367
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial resistance among clinical
Wu Q; Vaziri AZ; Omidi N; Hassan Kaviar V; Maleki A; Khadivar P; Kouhsari E
Pathog Glob Health; 2023 May; 117(3):235-244. PubMed ID: 35983997
[TBL] [Abstract][Full Text] [Related]
7. A systematic review and meta-analysis on the epidemiology of antibiotic resistance of Vibrio cholerae in Iran.
Yousefi A; Vaez H; Sahebkar A; Khademi F
Ann Ig; 2019; 31(3):279-290. PubMed ID: 31069372
[TBL] [Abstract][Full Text] [Related]
8. Antibiotics resistance in El Tor Vibrio cholerae 01 isolated during cholera outbreaks in Mozambique from 2012 to 2015.
Dengo-Baloi LC; Semá-Baltazar CA; Manhique LV; Chitio JE; Inguane DL; Langa JP
PLoS One; 2017; 12(8):e0181496. PubMed ID: 28792540
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Ciprofloxacin for Treatment of Cholera Associated with Diminished Susceptibility to Ciprofloxacin to Vibrio cholerae O1.
Khan WA; Saha D; Ahmed S; Salam MA; Bennish ML
PLoS One; 2015; 10(8):e0134921. PubMed ID: 26271050
[TBL] [Abstract][Full Text] [Related]
10. Resistance of
Nateghizad H; Sajadi R; Shivaee A; Shirazi O; Sharifian M; Tadi DA; Amini K
Front Pharmacol; 2023; 14():1027277. PubMed ID: 37021056
[No Abstract] [Full Text] [Related]
11. Genetic relatedness, virulence factors and antibiotics susceptibility pattern of Vibrio cholerae isolates from various regions during cholera outbreak in Tanzania.
Matimba HH; Joachim A; Mizinduko MM; Maseke IA; Nyanga SK; Kelly ME; Nyanga AS; Mghamba JM; Majigo MV; Mohamed AA
PLoS One; 2022; 17(3):e0265868. PubMed ID: 35333909
[TBL] [Abstract][Full Text] [Related]
12. Identification of virulence factors in Vibrio cholerae isolated from Iraq during the 2007-2009 outbreak.
Saleh TH; Sabbah MA; Jasem KA; Hammad ZN
Can J Microbiol; 2011 Dec; 57(12):1024-31. PubMed ID: 22133188
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the efficacy of different antibiotics in inhibiting colonisation of Vibrio cholerae O1 in the rabbit intestine.
Chakrabarti MK; Bhattacharya MK; Sinha AK; Chatterjee DC; Bhattacharya SK
Zentralbl Bakteriol; 1993 Feb; 278(1):69-72. PubMed ID: 8518514
[TBL] [Abstract][Full Text] [Related]
14. Vibrio cholerae O1 Ogawa Strains Carrying the ctxB7 Allele Caused a Large Cholera Outbreak during 2014 in the Tribal Areas of Odisha, India.
Pal BB; Khuntia HK; Nayak SR; Mohanty A; Biswal B
Jpn J Infect Dis; 2017 Sep; 70(5):549-553. PubMed ID: 28674316
[TBL] [Abstract][Full Text] [Related]
15. Geographical distribution and antibiotics susceptibility patterns of toxigenic Vibrio cholerae isolates from Kisumu County, Kenya.
Awuor SO; Omwenga EO; Daud II
Afr J Prim Health Care Fam Med; 2020 Dec; 12(1):e1-e6. PubMed ID: 33354982
[TBL] [Abstract][Full Text] [Related]
16. Drug response and genetic properties of Vibrio cholerae associated with endemic cholera in north-eastern Thailand, 2003-2011.
Chomvarin C; Johura FT; Mannan SB; Jumroenjit W; Kanoktippornchai B; Tangkanakul W; Tantisuwichwong N; Huttayananont S; Watanabe H; Hasan NA; Huq A; Cravioto A; Colwell RR; Alam M
J Med Microbiol; 2013 Apr; 62(Pt 4):599-609. PubMed ID: 23319310
[TBL] [Abstract][Full Text] [Related]
17. Relationships among ciprofloxacin, gatifloxacin, levofloxacin, and norfloxacin MICs for fluoroquinolone-resistant Escherichia coli clinical isolates.
Becnel Boyd L; Maynard MJ; Morgan-Linnell SK; Horton LB; Sucgang R; Hamill RJ; Jimenez JR; Versalovic J; Steffen D; Zechiedrich L
Antimicrob Agents Chemother; 2009 Jan; 53(1):229-34. PubMed ID: 18838594
[TBL] [Abstract][Full Text] [Related]
18. Genetic characteristics of drug-resistant Vibrio cholerae O1 causing endemic cholera in Dhaka, 2006-2011.
Rashed SM; Mannan SB; Johura FT; Islam MT; Sadique A; Watanabe H; Sack RB; Huq A; Colwell RR; Cravioto A; Alam M
J Med Microbiol; 2012 Dec; 61(Pt 12):1736-1745. PubMed ID: 22977073
[TBL] [Abstract][Full Text] [Related]
19. Outbreak of cholera caused by Vibrio cholerae 01 intermediately resistant to norfloxacin at Malda, West Bengal.
Bhattacharya MK; Ghosh S; Mukhopadhyay AK; Deb A; Bhattacharya SK
J Indian Med Assoc; 2000 Jul; 98(7):389-90. PubMed ID: 11143861
[TBL] [Abstract][Full Text] [Related]
20. Expanding multiple antibiotic resistance among clinical strains of Vibrio cholerae isolated from 1992-7 in Calcutta, India.
Garg P; Chakraborty S; Basu I; Datta S; Rajendran K; Bhattacharya T; Yamasaki S; Bhattacharya SK; Takeda Y; Nair GB; Ramamurthy T
Epidemiol Infect; 2000 Jun; 124(3):393-9. PubMed ID: 10982062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
